Search

everythinglearnresearchcommunity

for

Search:↓

During COVID-19, Iraqi women saw more hair loss and skin issues like acne due to stress, masks, and hygiene habits.

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

During COVID-19, Iraqi women experienced more hair loss and skin issues like acne, likely due to stress and mask-wearing.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Diet can influence inflammatory skin diseases.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Gut health affects skin diseases, and probiotics might help.

Cannabinoids may help some skin conditions but more research is needed.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

JAK inhibitors show promise for treating various skin diseases.